Individuals Stopping Weight-Loss Jabs Regain Weight Far More Rapidly Than People Using Diet and Exercise

A recent study reveals that individuals who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who end conventional diet and exercise programs.

Findings released in a prominent health publication points out that while obese people can lose a large proportion of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.

"Users buying these treatments must be aware of the risk of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

This pace of regain implies a return to starting mass within about a year and a half.

Analyzing Treatments

The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of the injectable medications with older methods.

The team note that people who lose weight through diet and exercise usually see a less rapid creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Rebound

Nutrition scientists propose the way of the drugs explains the accelerated rebound.

The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Long-term administration of the hormone levels far above than the body's typical production may cause the body to produce less of its own natural hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement leads to appetite is no longer kept in check, making binge eating far more likely."

A Lifelong Disease?

The NHS suggest the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.

A number of clinicians say that, given the significant potential of relapse, the treatment should be considered life-long.

This perspective is supported by pharmaceutical companies, who say that the findings "emphasize the chronic character of excess weight," comparing it to managing diseases like high blood pressure.

Patient Testimonies

People who have discontinued the medication explain a powerful resurgence of cravings.

"It felt as if a switch that goes on and you become starving," recalled a patient.

This challenge is exacerbated if users have not established permanent dietary or behavioural modifications during therapy.

Significant Interest

Survey data suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Use is more common among women than males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

Finally, experts emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a magic cure and long-term success likely depends on integrated lifestyle management.